Zhang et al. reported that ASNS is overexpressed in HCC and is associated with serum α-fetoprotein levels, tumor size, stage, and vascular invasion; however, patients with lower ASNS expression exhibited poorer overall survival outcomes. The gene discussed is ASNS; the disease is hepatocellular carcinoma.